ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
23.23
-0.40 (-1.71%)
At close: Jun 13, 2025, 4:00 PM
23.27
+0.04 (0.19%)
After-hours: Jun 13, 2025, 4:02 PM EDT
ArriVent BioPharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$39.29
Upside
+69.17%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +72.23% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +72.23% | May 14, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +59.31% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +93.76% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +67.92% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $39 | Strong Buy | Maintains | $36 → $39 | +67.92% | Jan 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +55.01% | Nov 15, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $36 | Strong Buy | Maintains | $30 → $36 | +55.01% | Sep 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $35 → $39 | Buy | Reiterates | $35 → $39 | +67.92% | Sep 10, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $38 | Strong Buy | Maintains | $28 → $38 | +63.62% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $36 | Strong Buy | Maintains | $30 → $36 | +55.01% | Sep 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +29.17% | Aug 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $35 | Buy | Reiterates | $35 | +50.70% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +7.64% | Jun 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +7.64% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +7.64% | Apr 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.